Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

53.92
Delayed Data
As of Sep 30
 +0.05 / +0.09%
Today’s Change
53.76
Today|||52-Week Range
77.12
-21.62%
Year-to-Date
3 Top Healthcare Stocks to Buy Now
Sep 30 / MotleyFool.com - Paid Partner Content
Bristol, Nektar Research Pact Aims to Boost Efficacy of Cancer Immunotherapy
Sep 27 / TheStreet.com - Paid Partner Content
3 Stocks to Own for the Next Decade
Sep 30 / MotleyFool.com - Paid Partner Content
Dr. Lisa Bardacks Faustian Bargain
Sep 25 / Investing Channel - Paid Partner Content
Two Stocks Teach a Lesson About Losses
Sep 29 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO
Sep 23 / Zacks.com - Paid Partner Content
52-Week Company Lows
Sep 29 / GuruFocus News - Paid Partner Content
Gilead to Stop GS-5745 Development for Ulcerative Colitis
Sep 22 / Zacks.com - Paid Partner Content
Bristol-Myers, Nektar Tie-Up for Opdivo/NKTR-214 Combo
Sep 28 / Zacks.com - Paid Partner Content
Bristol-Myers Opdivo's Regulatory Application Validated in EU
Sep 21 / Zacks.com - Paid Partner Content
Bristol-Myers Squibb Slides Into Value-Stock Territory
Sep 28 / TheStreet.com - Paid Partner Content
Opinions split on Witty regime at GSK
Sep 20 / FT.com - Paid Partner Content
Jim Cramer's Top Takeaways: Thor Industries, e.l.f. Beauty, Bristol-Myers Squibb
Sep 28 / TheStreet.com - Paid Partner Content